Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Clinical Genetics Dr Carole Brewer, Consultant Geneticist General Cancer Rules: Any first degree relative affected doubles index patient risk, however Some cancers have stronger genetic influence e.g. 1st degree relative with Thyroid cancer gives you an 8-fold increased risk. Some cancers have more environmental influence e.g. only 1.4 fold increased risk of relative has Bladder cancer. Smoker s automatically double their risk of pancreatic cancer. Ovarian Cancer Population risk 1/48 No evidence-based screening- USS not very helpful as some ovarian cancers disseminate early. “Empiric risk”: Number of Relatives Affected 1 1 2 2 Age affected < 50yr 50-60yr < 60 >60 Risk 1/15 1/25- 1/25 1/5 1/10 Colo-rectal Cancers Population risks: Males 1/18 Females 1/20 “Amsterdam criteria” can be used to risk categorise families – take into account numbers of relatives affected, number of generations and age of onset. E.g. 3 relatives have colorectal cancer, 2 generations and one relative diagnosed at < 50yrs very likely to have inherited cancer such as Lynch syndrome (previously known as hereditary non-polyposis colorectal cancer- HNPCC). BSG guidelines are then used to indicate interval of colonoscopy screening: High risk High moderate risk Low moderate risk 2 yearly 5yearly 50-75yr 1x only at 55yr Lynch syndrome associated with more right sided colon cancers, with rapidly progressive adenoma to adenocarcinoma and uterine carcinoma. All 1st degree relative need 18-24 monthly colonoscopy from 25ys age. Tumour tissue immunochemistry and samples can be kept for future reference- 90% are inherited and 10% sporadic. 4 genetic mutations have been identified: MLH1, MSH2, MSH6, and PMS2. Blood genetic testing is very expensive £600 per gene. If gene mutation is detected, predictive testing may be possible for relatives and if negative for the mutation they can be relegated to the normal population risk (1/18) and no need for 2 yearly colonoscopy. Study 2011 by John Burn (CAPP2 study) showed high dose aspirin, 600mg over 2 years reduced risk of colon cancer by 60%. So refer 1) For risk assessment where there is a complex FH 2) Genetic testing – ideally if affected relative available for tissue sample. Breast cancer BRCA2 associated with moderate increased risk of prostate, pancreas and stomach. DNA from affected case can be used for genetic testing in future. For patients concerned about breast cancer , the Manchester scoring system recommended by NICE to risk score patient for BRCA1/ 2 testing . Takes in to account number of relative affected from he same lineage, age at incidence, history ovarian, pancreatic cancer, histology of cancer. Testing recommended if > 20%risk. Prostate Cancer No specific gene but “familial aggregation”. Lots of “small genes” involved FH doubles risk. Consider PSA testing is relative affected at <60y Procedures after referral to Genetics Clinic TRIAGE CANCER MANAGEMENT SYSTEM : includes 1) Consent to access records patient 3) Contact Cancer registry 4) Review histology READY TO REVIEW PATIENT NURSE COUNSELLOR CONSULTANT CLINIC 2 ) Letter to